Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ideaya Biosciences, Inc. (IDYA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 72,130,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   IDEAYA Biosciences is a synthetic lethality-focused precision medicine oncology company engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Co.'s primary synthetic lethality product candidate is IDE397, a clinical-stage methionine adenosyltransferase 2a inhibitor for patients with solid tumors having methylthioadenosine phosphorylase deletions. Co. is enrolling patients into a Phase 1 clinical trial designated as IDE397-001 to evaluate IDE397. Co. is targeting poly (ADP-ribose) glycohydrolase for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 101,372 268,000 311,470 311,470
Total Sell Value $4,587,595 $10,832,803 $11,979,134 $11,979,134
Total People Sold 2 3 4 4
Total Sell Transactions 3 11 26 26
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 129
  Page 3 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-09-07 4 AS $27.46 $3,185 D/D (116) 78,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-09-07 4 OE $4.31 $500 D/D 116 78,905     -
   Stone Paul A. SVP, Chief Financial Officer   •       –      –    2021-09-07 4 AS $27.42 $68,543 D/D (2,500) 12,944     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-09-02 4 AS $25.09 $250,943 D/D (10,000) 78,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-08-09 4 AS $22.96 $264,269 D/D (11,500) 88,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-08-09 4 OE $4.31 $6,465 D/D 1,500 100,289     -
   Throne Jason SVP, General Counsel   •       –      –    2021-07-27 4 AS $25.17 $251,683 D/D (10,000) 0     -
   Throne Jason SVP, General Counsel   •       –      –    2021-07-27 4 OE $13.34 $133,400 D/D 10,000 10,000     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-07-27 4 AS $25.15 $251,460 D/D (10,000) 98,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-07-27 4 OE $4.31 $56,150 D/D 10,000 108,789     -
   Throne Jason SVP, General Counsel   •       –      –    2021-07-06 4 AS $22.16 $222,408 D/D (10,000) 0     -
   Throne Jason SVP, General Counsel   •       –      –    2021-07-06 4 OE $7.01 $85,229 D/D 10,000 10,000     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-07-06 4 AS $22.20 $33,358 D/D (1,500) 98,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-07-06 4 OE $6.92 $10,380 D/D 1,500 100,289     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-06-17 4 AS $22.49 $87,540 D/D (3,893) 98,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-06-17 4 OE $6.92 $26,940 D/D 3,893 102,682     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-06-16 4 AS $22.47 $24,873 D/D (1,107) 98,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-06-16 4 OE $6.92 $7,660 D/D 1,107 99,896     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-06-07 4 AS $20.22 $30,333 D/D (1,500) 98,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-06-07 4 OE $6.92 $10,380 D/D 1,500 100,289     -
   Stone Paul A. SVP, Chief Financial Officer   •       –      –    2021-05-28 4 A $11.36 $9,762 D/D 859 13,803     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-05-11 4 AS $20.22 $101,093 D/D (5,000) 98,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-05-11 4 OE $6.92 $34,600 D/D 5,000 103,789     -
   Lackner Mark SVP, Head of Biology   •       –      –    2021-02-10 4 AS $21.00 $12,516 D/D (596) 0     -
   Lackner Mark SVP, Head of Biology   •       –      –    2021-02-10 4 OE $6.98 $4,160 D/D 596 596     -
  129 Records found
  1  2  3  4  5  6   
  Page 3 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us